Menu

Prescribing guidelines

Loading…

April 2022 - APC Approved list of guideline review date extensions (to 3 years from date approved)

CNS: Antiplatelet Guidelines for the prevention and treatment of cerebrovascular and cardiovascular conditions (APC Approved)

Brain and mental health Cardiovascular and Lipids
CVS: Anticoagulant plus Antiplatelet Combined Therapy Guidance

Brain and mental health Cardiovascular and Lipids
CVS: Anticoagulation- BHNFT- perioperative bridging guidelines

Cardiovascular and Lipids
CVS: Anticoagulation- Non valvular AF - guidance

Cardiovascular and Lipids
CVS: Barnsley Lipid Management for Primary Prevention of CVD in Adults
CVS: Barnsley Lipid Optimisation for Secondary Prevention
CVS: Barnsley Severe Hyperlipidaemia Pathway (APC Approved)
CVS: Choice of DOAC for prevention of stroke and systemic embolism in adults with NVAF APC position statement

Cardiovascular and Lipids
CVS: Chronic Coronary Syndrome - Stable Angina (APC Approved)

Cardiovascular and Lipids
CVS: Furosemide (frusemide)- Guidance for prescribing Subcutaneous Furosemide

Cardiovascular and Lipids

Guidance for the assessment and treatment of end stage heart failure by subcutaneous furosemide for the treatment of symptomatic fluid overload

Did you find this page helpful?